Transmissible spongiform encephalopathies

被引:175
作者
Collins, SJ [1 ]
Lawson, VA
Masters, CL
机构
[1] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
[2] Australian Natl Creutzfeldt Jakob Dis Registry, Melbourne, Vic, Australia
[3] Mental Hlth Res Inst Victoria, Melbourne, Vic, Australia
关键词
D O I
10.1016/S0140-6736(03)15171-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nosologically, transmissible spongiform encephalopathies (TSE or prion diseases) should be grouped with other neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, which are all caused by toxic gain of function of an aberrant form of a constitutively expressed protein. Failure to clear these proteins from the brain induces neuronal dysfunction. Transmissibility is the property that separates TSE from other neurodegenerative diseases, and this property seems to reside within the structure of the abnormal protein. The human phenotypic range of these encephalopathies includes Creutzfeldt-Jakob disease and its variant form, kuru, Gerstmann-Straussler-Scheinker syndrome, and fatal familial insomnia. Notwithstanding the generally low incidence of TSE and their limited infectiousness, major epidemics such as bovine spongiform encephalopathy and kuru arise in situations where intraspecies recycling of the abnormal protein is sustained. Moreover, evidence of chronic subclinical infection in animals offers insights into pathogenesis and prompts re-evaluation of the notion of species barriers and present infection control measures. Since case-to-case transmission is the only known mechanism underlying epidemics of TSE, potential reservoirs of infectivity in the tails of epidemics need continued vigilance.
引用
收藏
页码:51 / 61
页数:11
相关论文
共 129 条
[1]  
ANDREWS NJ, 2003, INCIDENCE VARIANT CR
[2]   BSE priors propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein [J].
Asante, EA ;
Linehan, JM ;
Desbruslais, M ;
Joiner, S ;
Gowland, I ;
Wood, AL ;
Welch, J ;
Hill, AF ;
Lloyd, SE ;
Wadsworth, JDF ;
Collinge, J .
EMBO JOURNAL, 2002, 21 (23) :6358-6366
[3]   Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrPSc) into contiguous membranes [J].
Baron, GS ;
Wehrly, K ;
Dorward, DW ;
Chesebro, B ;
Caughey, B .
EMBO JOURNAL, 2002, 21 (05) :1031-1040
[4]   Evaluation of quinacrine treatment for prion diseases [J].
Barret, A ;
Tagliavini, F ;
Forloni, G ;
Bate, C ;
Salmona, M ;
Colombo, L ;
De Luigi, A ;
Limido, L ;
Suardi, S ;
Rossi, G ;
Auvré, F ;
Adjou, KT ;
Salès, N ;
Williams, A ;
Lasmézas, C ;
Deslys, JP .
JOURNAL OF VIROLOGY, 2003, 77 (15) :8462-8469
[5]   Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers [J].
Barron, RM ;
Thomson, V ;
Jamieson, E ;
Melton, DW ;
Ironside, J ;
Will, R ;
Manson, JC .
EMBO JOURNAL, 2001, 20 (18) :5070-5078
[6]   14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease [J].
Beaudry, P ;
Cohen, P ;
Brandel, JP ;
Delasnerie-Lauprêtre, N ;
Richard, S ;
Launay, JM ;
Laplanche, JL .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (01) :40-46
[7]   IDENTIFICATION OF A PROTEIN THAT PURIFIES WITH THE SCRAPIE PRION [J].
BOLTON, DC ;
MCKINLEY, MP ;
PRUSINER, SB .
SCIENCE, 1982, 218 (4579) :1309-1311
[8]   Prions in skeletal muscle [J].
Bosque, PJ ;
Ryou, C ;
Telling, G ;
Peretz, D ;
Legname, G ;
DeArmond, SJ ;
Prusiner, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :3812-3817
[9]   Spongiform encephalopathies - B lymphocytes and neuroinvasion [J].
Brown, P .
NATURE, 1997, 390 (6661) :662-663
[10]   HUMAN SPONGIFORM ENCEPHALOPATHY - THE NATIONAL-INSTITUTES-OF-HEALTH SERIES OF 300 CASES OF EXPERIMENTALLY TRANSMITTED DISEASE [J].
BROWN, P ;
GIBBS, CJ ;
RODGERSJOHNSON, P ;
ASHER, DM ;
SULIMA, MP ;
BACOTE, A ;
GOLDFARB, LG ;
GAJDUSEK, DC .
ANNALS OF NEUROLOGY, 1994, 35 (05) :513-529